For investors looking to join solid core business progress with positive chart formations, a multi-factor method can be useful. One technique involves searching for stocks that show high growth basics, as judged by measures like earnings speed and estimate changes, while also showing sound technical condition and a tightening price formation ready for a possible move higher. This approach tries to find companies where strong earnings progress is matching with a technically good arrangement, possibly giving a good balance of risk and reward for entry.
GENMAB A/S -SP ADR (NASDAQ:GMAB) appears as a candidate matching this description. The Danish biotechnology firm, recognized for creating antibody treatments for cancer and other illnesses, displays an interesting mix of basic growth and technical condition.
Basic Growth Progress
The ChartMill High Growth Progress Rating for GMAB is at a firm 6 out of 10, pointing to a good degree of earnings and sales progress. This number combines several important growth parts that are vital for progress investors. A closer inspection of the given data shows the reasons for this rating:
- Outstanding Earnings Increase: The company has shown very high earnings per share (EPS) increase on a trailing twelve-month (TTM) basis, up about 126%. Recent three-month period performance has been especially solid, with the last reported quarter showing year-over-year EPS increase of over 121%.
- Positive Estimate Changes: Analyst feeling has become more positive, a key part of the progress rating. The average EPS guess for the next fiscal year has been adjusted higher by almost 12% over the past three months, showing increasing belief in the company's short-term profit possibility.
- Solid Profitability Growth: The company's profit margin has shown important growth. The last reported three-month period profit margin of 39.2% shows a large rise from 27.3% two quarters before, showing a better ability to turn revenue into earnings.
- Steady Earnings Beats: GMAB has surpassed EPS guesses in each of the past four quarters, with an average beat of over 61%. This steady ability to go beyond expectations builds trust with investors and is a sign of positive progress.
While recent three-month period sales increase has been uneven, the solid TTM revenue increase of almost 25% and the growth in profitability and earnings highlight the basic growth story. These factors, speeding earnings, growing margins, positive beats, and higher adjustments, are exactly what the High Growth Progress Rating aims to find, making GMAB a relevant candidate for this method.
Technical Condition and Formation Quality
Beyond the basics, GMAB shows an interesting technical view. According to the detailed ChartMill Technical Analysis report, the stock gets a complete Technical Rating of 10 out of 10 and a Formation Rating of 7.
- Technical Condition (Rating: 10): This highest score shows outstanding technical strength. Both the short-term and long-term directions are firmly positive. The stock is trading above all its main moving averages (20, 50, 100, and 200-day), which are all in a rising arrangement. Also, its one-year performance puts it in the top 10% of all stocks, showing clear market strength.
- Tightening Formation (Rating: 7): The Formation Rating of 7 shows the stock is building a constructive pattern. The analysis states that prices have been tightening recently inside a set range, with lower movement, a typical condition before a move higher. This tightening lets the stock absorb its earlier gains and form a base for its next possible step.
- Support and Resistance: The technical report finds a clear support area between $31.61 and $32.04, made by a mix of trend lines and moving averages. A clear move above the noted resistance near $34.27 could show the start of a new upward phase. This set formation allows for a careful trading method with clear points for entry and stop-loss placement.
Summary
GENMAB A/S shows a situation where solid basic growth progress meets a technically sound chart. The company's strong earnings increase, margin growth, and positive analyst adjustments meet the main needs for high-growth progress investing. At the same time, its complete technical rating confirms a solid upward direction, while the formation rating suggests it is tightening in a way that may come before a new move higher. For investors using a method that looks for both basic progress and technical formation quality, GMAB deserves more study.
Interested in finding more stocks that meet similar needs of high growth progress and technical move higher formations? You can run the search yourself using this link: High Growth Progress Move Higher Formations Search.
,
Disclaimer: This article is for information only and does not make up investment guidance, a suggestion, or a deal or request to buy or sell any securities. The study is based on given data and shows conditions at a specific time. Investing includes risk, including the possible loss of original money. Always do your own research and think about talking with a qualified financial advisor before making any investment choices.